88 related articles for article (PubMed ID: 8680807)
1. Effects of monoisoamyl meso-2,3-dimercaptosuccinate on arsenite-induced maternal and developmental toxicity in mice.
Domingo JL; Gómez M; Sánchez DJ; Llobet JM; Jones MM; Singh PK
Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):389-400. PubMed ID: 8680807
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the protective activity of monisoamyl meso-2,3-dimercaptosuccinate against methylmercury-induced maternal and embryo/fetal toxicity in mice.
Bellés M; Sánchez DJ; Gómez M; Domingo JL; Jones MM; Singh PK
Toxicology; 1996 Jan; 106(1-3):93-7. PubMed ID: 8571406
[TBL] [Abstract][Full Text] [Related]
3. Developmental toxicity evaluation of monoisoamyl meso-2,3-dimercaptosuccinate in mice.
Bosque MA; Domingo JL; Corbella J; Jones MM; Singh PK
J Toxicol Environ Health; 1994 Aug; 42(4):443-50. PubMed ID: 8051718
[TBL] [Abstract][Full Text] [Related]
4. meso-2,3-Dimercaptosuccinic acid and prevention of arsenite embryotoxicity and teratogenicity in the mouse.
Domingo JL; Bosque MA; Piera V
Fundam Appl Toxicol; 1991 Aug; 17(2):314-20. PubMed ID: 1662650
[TBL] [Abstract][Full Text] [Related]
5. Effect of monoisoamyl meso-2,3-dimercaptosuccinate on the pathology of acute cadmium intoxication.
Xu C; Holscher MA; Jones MM; Singh PK
J Toxicol Environ Health; 1995 Jul; 45(3):261-77. PubMed ID: 7609002
[TBL] [Abstract][Full Text] [Related]
6. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
Kostial K; Kargacin B; Blanusa M; Piasek M; Jones MM; Singh PK
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123
[TBL] [Abstract][Full Text] [Related]
7. Reduction of lead retention by mono-3-methylbutan-1-yl meso-2,3-dimercaptosuccinate in suckling rats.
Blanusa M; Kostial K; Piasek M; Jones MM; Singh PK
Analyst; 1995 Mar; 120(3):951-3. PubMed ID: 7741262
[TBL] [Abstract][Full Text] [Related]
8. Antidotal efficacy of newly synthesized dimercaptosuccinic acid (DMSA) monoesters in experimental arsenic poisoning in mice.
Kreppel H; Reichl FX; Kleine A; Szinicz L; Singh PK; Jones MM
Fundam Appl Toxicol; 1995 Jul; 26(2):239-45. PubMed ID: 7589912
[TBL] [Abstract][Full Text] [Related]
9. Amelioration by BAL (2,3-dimercapto-1-propanol) and DMPS (sodium 2,3-dimercapto-1-propanesulfonic acid) of arsenite developmental toxicity in mice.
Domingo JL; Bosque MA; Llobet JM; Corbella J
Ecotoxicol Environ Saf; 1992 Jun; 23(3):274-81. PubMed ID: 1376232
[TBL] [Abstract][Full Text] [Related]
10. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats.
Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 1995 Sep; 77(3):216-8. PubMed ID: 8884886
[TBL] [Abstract][Full Text] [Related]
11. Mobilization of lead in mice by administration of monoalkyl esters of meso-2,3-dimercaptosuccinic acid.
Walker EM; Stone A; Milligan LB; Gale GR; Atkins LM; Smith AB; Jones MM; Singh PK; Basinger MA
Toxicology; 1992 Nov; 76(1):79-87. PubMed ID: 1335621
[TBL] [Abstract][Full Text] [Related]
12. Monoisoamyl dimercaptosuccinic acid induced changes in pregnant female rats during late gestation and lactation.
Mehta A; Pant SC; Flora SJ
Reprod Toxicol; 2006 Jan; 21(1):94-103. PubMed ID: 16040228
[TBL] [Abstract][Full Text] [Related]
13. Monoisoamyl meso-2,3-dimercaptosuccinate: interaction with metallothionein-bound cadmium in vitro and evidence of active transport into renal and hepatic cells in vivo.
Tasende MS; Gale GR; Smith AB; Jones MM; Singh PK
Res Commun Chem Pathol Pharmacol; 1992 Jun; 76(3):323-39. PubMed ID: 1636055
[TBL] [Abstract][Full Text] [Related]
14. Effect of chelators, monoisoamyl meso-2,3-dimercaptosuccinate and N-(4-methylbenzyl)-4-O-(beta-D-galactopyranosyl)-D-glucamine-N-carbodit hioate, on cadmium and essential element levels in mice.
Eybl V; Kotyzová D; Koutenský J; Jones MM; Singh PK
Analyst; 1995 Mar; 120(3):855-7. PubMed ID: 7741241
[TBL] [Abstract][Full Text] [Related]
15. Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats.
Kostial K; Blanusa M; Piasek M; Simonović I; Jones MM; Singh PK
Arh Hig Rada Toksikol; 1993 Sep; 44(3):217-22. PubMed ID: 8311694
[TBL] [Abstract][Full Text] [Related]
16. meso-2,3-dimercaptosuccinic acid monoalkyl esters: effects on mercury levels in mice.
Gale GR; Smith AB; Jones MM; Singh PK
Toxicology; 1993 Jul; 81(1):49-56. PubMed ID: 8396277
[TBL] [Abstract][Full Text] [Related]
17. Developmental toxicity of subcutaneously administered meso-2,3-dimercaptosuccinic acid in mice.
Domingo JL; Paternain JL; Llobet JM; Corbella J
Fundam Appl Toxicol; 1988 Nov; 11(4):715-22. PubMed ID: 2852612
[TBL] [Abstract][Full Text] [Related]
18. Effects of combined administration of captopril and DMSA on arsenite induced oxidative stress and blood and tissue arsenic concentration in rats.
Kalia K; Narula GD; Kannan GM; Flora SJ
Comp Biochem Physiol C Toxicol Pharmacol; 2007 Jan; 144(4):372-9. PubMed ID: 17188940
[TBL] [Abstract][Full Text] [Related]
19. Design of in vivo cadmium-mobilizing agents: synthesis and properties of monobenzyl meso-2,3-dimercaptosuccinate.
Jones MM; Singh PK; Basinger MA; Gale GR; Smith AB; Harris WR
Chem Res Toxicol; 1994; 7(3):367-73. PubMed ID: 8075368
[TBL] [Abstract][Full Text] [Related]
20. Meso-2,3-dimercaptosuccinic acid (DMSA) affects maternal and fetal copper metabolism in Swiss mice.
Taubeneck MW; Domingo JL; Llobet JM; Keen CL
Toxicology; 1992; 72(1):27-40. PubMed ID: 1311466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
